Clinical Research Directory
Browse clinical research sites, groups, and studies.
Back to Studies
RECRUITING
NCT07205289
PHASE1
Serum Collection Study for Assay Development
Sponsor: GPN Vaccines
View on ClinicalTrials.gov
Summary
The study will collect serum from 12 participants vaccinated with Gamma-PN to assist with assay development and validation
Official title: A Phase 1B Open-label Study to Collect Serum Following Vaccination With Killed Whole-cell Pneumococcal Vaccine (Gamma-PN) in Adults for Use in Assay Validation
Key Details
Gender
All
Age Range
18 Years - 69 Years
Study Type
INTERVENTIONAL
Enrollment
12
Start Date
2025-10
Completion Date
2026-06
Last Updated
2025-10-03
Healthy Volunteers
Yes
Interventions
BIOLOGICAL
Gamma-PN
Killed whole-cell pneumococcal vaccine
Locations (1)
University of Adelaide Clinical Research Facility
Adelaide, South Australia, Australia